Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Ikonisys Receives FDA Clearance For Non-Invasive, HER-2 Breast Cancer Test
http://www.medicalnewstoday.com/articles/127374.php
Ikonisys, a leading provider of next generation, non-invasive, cell-based diagnostic solutions, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its oncoFISH her2 test.
New Report Shows Media Coverage Of Lung Cancer Is Increasing, And Increasingly Negative
http://www.medicalnewstoday.com/articles/127361.php
CancerCare has announced that despite an overall increase in news reporting on lung cancer, the overall tone of lung cancer media coverage has become significantly more negative. "How the U.S.
Phase 1 Clinical Trial Of PV-10 In Recurrent Breast Cancer Complete, Says Provectus Pharmaceuticals
http://www.medicalnewstoday.com/articles/127343.php
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced that it has successfully completed its Phase 1 clinical trial of PV-10 in the treatment of recurrent breast carcinoma.
Breast Cancer Radiation Device Prompts Concerns Over FDA Quick-Review Process
http://www.medicalnewstoday.com/articles/127254.php
<BR>A device to treat breast cancer that was cleared for use in the U.S. under <A href="http://www.fda.gov/" target=_new>FDA</A>'s quick-review process raises concerns from critics that the agency is not thoroughly vetting some experimental medical devices before approval, the <A href="http://www.
Breast Cancer - IU School Of Medicine Researchers Earn Susan G. Komen For The Cure Grants
http://www.medicalnewstoday.com/articles/127224.php
Faculty members of the Indiana University School of Medicine have been awarded research grants from Susan G. Komen for the Cure. John Foley, Ph.D., David Gilley, Ph.D., and Hiromi Tanaka, Ph.
----------------------------------------------
** CANCER / ONCOLOGY News **
Ikonisys Receives FDA Clearance For Non-Invasive, HER-2 Breast Cancer Test
http://www.medicalnewstoday.com/articles/127374.php
Ikonisys, a leading provider of next generation, non-invasive, cell-based diagnostic solutions, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its oncoFISH her2 test.
Published Preclinical Study Shows Receptor BioLogix's Pan-HER Ligand Trap Has Broad Anti-Cancer Activity
http://www.medicalnewstoday.com/articles/127371.php
Receptor BioLogix, Inc., today announced that a new publication in the journal<i> Molecular Cancer Therapeutics1</i> confirms the broad anti-cancer potential of its pan-HER (human EGF receptor) ligand traps, which are novel fusion proteins designed to significantly improve the response rate and increase the survival of patients with HER-related cancers.
Onconova Announces Publication Of Positive Phase I Results For Lead Anticancer Compound In Journal Of Clinical Oncology
http://www.medicalnewstoday.com/articles/127368.php
Onconova Therapeutics, Inc. announced today the publication of positive results from a first-in-human Phase I clinical trial of its lead anticancer drug, ON 01910.Na, in advanced refractory solid tumors.
Merck Serono And Lpath Form Alliance For ASONEP, A Phase I Monoclonal Antibody, Across All Indications
http://www.medicalnewstoday.com/articles/127359.php
Merck Serono, a division of Merck KGaA, announced today that it has entered a worldwide alliance with Lpath, Inc. (OTCBB:LTPN) of the United States to develop and commercialize ASONEP, a Phase I monoclonal antibody currently being evaluated for the treatment of various cancer types.
Phase 1 Clinical Trial Of PV-10 In Recurrent Breast Cancer Complete, Says Provectus Pharmaceuticals
http://www.medicalnewstoday.com/articles/127343.php
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced that it has successfully completed its Phase 1 clinical trial of PV-10 in the treatment of recurrent breast carcinoma.
Cancer Drug Development Could Benefit From Improved Rodent Trials
http://www.medicalnewstoday.com/articles/127334.php
Better design of rodent trials could reduce the cost and time required for cancer drug development, according to a commentary in the October 28 online issue of the <i>Journal of the National Cancer Institute</i>.
News From The Journal Of The National Cancer Institute, Oct. 28
http://www.medicalnewstoday.com/articles/127287.php
<b>Skewed X Inactivation in BRCA1 Mutation Carriers</b>One X chromosome is more frequently silenced than the other X chromosome in women who carry mutations in the BRCA1 gene, and the skewed X inactivation is associated with a later onset of breast or ovarian cancer in these women.
World First Early Stage Diagnostic Test For Ovarian Cancer
http://www.medicalnewstoday.com/articles/127256.php
There is new hope for women around the world, with the launch of an early detection test for ovarian cancer. The test, developed in Melbourne by HealthLinx scientists in collaboration with ARL Pathology, is called the OvPlex™ Panel and works by identifying whether five biomarkers (proteins) are present in a blood sample.
Cleveland BioLabs Protectan CBLB612 Demonstrates Significant Reduction Of Myelosuppression In Mouse Model Of Chemotherapy
http://www.medicalnewstoday.com/articles/127238.php
Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced results of a series of studies demonstrating Protectan CBLB612's ability to substantially reduce myelosuppression (the most common rate limiting adverse effect of chemotherapy) caused by a widely used chemotherapeutic drug, cyclophosphamide (Cytoxan, Neosar, CTX).
Breast Cancer - IU School Of Medicine Researchers Earn Susan G. Komen For The Cure Grants
http://www.medicalnewstoday.com/articles/127224.php
Faculty members of the Indiana University School of Medicine have been awarded research grants from Susan G. Komen for the Cure. John Foley, Ph.D., David Gilley, Ph.D., and Hiromi Tanaka, Ph.
Nanocenter Offers Promising Non-Invasive Cancer Treatment
http://www.medicalnewstoday.com/articles/127220.php
A team of scientists at Arkansas Nanotechnology Center at UALR (the University of Arkansas at Little Rock) has developed what promises to be a non-invasive method of eradicating cancer cells while reducing the life-threatening side effects of chemotherapy and radiation.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Pivotal Study Of SoftPAP Collector Demonstrates Significant Improvements Over Conventional Collection Technique For PAP Sample
http://www.medicalnewstoday.com/articles/127376.php
CytoCore Inc. (OTCBB:CYOE), the developer of cost-effective, screening systems for early detection of gynecological cancers and sexually transmitted diseases, today announced the data analysis from its 703 patient clinical trial on Adequacy, Efficacy and Safety between the SoftPAP® Collector compared to the standard Spatula/CytoBrush Technique.
Fewer Women Than Ever Before Need Their Cervical Screening Test Repeated, UK
http://www.medicalnewstoday.com/articles/127200.php
Fewer women than ever before are having to give a repeat cervical screening sample because the first proved inadequate; a new report from The NHS Information Centre shows today. Less than 100,000 women had to have a repeat screening in 2007-08, with the rate of inadequate screening samples now at its lowest level ever (2.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
New Report Shows Media Coverage Of Lung Cancer Is Increasing, And Increasingly Negative
http://www.medicalnewstoday.com/articles/127361.php
CancerCare has announced that despite an overall increase in news reporting on lung cancer, the overall tone of lung cancer media coverage has become significantly more negative. "How the U.S.
Video-Assisted Thoracic Surgery Offers Comprehensive Cancer Removal Compared To Open Surgery
http://www.medicalnewstoday.com/articles/127348.php
Minimally-invasive surgery for lung cancer called video-assisted thoracic surgery or VATS is a relatively new procedure performed almost exclusively at academic centers. Now, a preliminary study to be presented this month at the annual CHEST meeting in Philadelphia is giving surgeons an early look at its benefits.
New Lung Cancer Research Presented At CHEST 2008
http://www.medicalnewstoday.com/articles/127326.php
<b>#7725YOUNGER PATIENTS WITH LUNG CANCER HAVE BETTER SURVIVAL</b>Lung cancer in younger patients may exhibit distinct clinical features than lung cancer in older patients, including better survival rates at each disease stage.
News Briefs Highlight Research In Pulmonary, Critical Care And Sleep Medicine At CHEST 2008
http://www.medicalnewstoday.com/articles/127285.php
<b>#7720PATIENTS' HOME PHOTOS HELP IDENTIFY ASTHMA TRIGGERS</b> The use of in-home photography may be a more cost-effective alternative to in-home inspections for identifying asthma and allergy triggers.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Gemin X Pan Bcl-2 Inhibitor Obatoclax Shows Biological, Clinical Activity In Heavily Pre-Treated Patients With Advanced Chronic Lymphocytic Leukemia
http://www.medicalnewstoday.com/articles/127337.php
Gemin X, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced that one of its lead oncology candidates, obatoclax, has demonstrated biological and anti-cancer activity in heavily pre-treated patients with advanced chronic lymphocytic leukemia (CLL).
New Way To Attack Some Forms Of Leukemia Discovered By Syracuse University Researchers
http://www.medicalnewstoday.com/articles/127301.php
Each year, some 29,000 adults and 2,000 children are diagnosed with leukemia, a form of cancer that is caused by the abnormal production of white blood cells in the bone marrow. Current treatments rely primarily on killing the cancer cells, which also destroys normal cells.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Reduction In Prostate Specific Antigen Levels Associated With Statin Use
http://www.medicalnewstoday.com/articles/127292.php
Use of cholesterol-lowering statins is associated with a statistically significant decline in prostate specific antigen (PSA) levels, according to a report in the October 28 online issue of the <i>Journal of the National Cancer Institute.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment